TRAW·68232V884·US·equity·Healthcare - Biotechnology-Activist
TRAW (TRAWS PHARMA INC) is held by 12 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($141,100), STATE STREET CORP ($47,218). Net institutional sentiment: Mixed.
See how TRAW's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer